Fresenius Medical Care AG (FMS) Long-Term Investments (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported Long-Term Investments for 17 consecutive years, with $772.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Long-Term Investments rose 16.45% year-over-year to $772.5 million; the TTM figure through Dec 2025 stood at $772.5 million (up 16.45% YoY), while the FY2025 annual figure was $772.5 million, up 16.45% from the prior year.
• Long-Term Investments came in at $772.5 million for Q4 2025 at Fresenius Medical Care AG, up from $6.7 million in the prior quarter.
• The five-year high for Long-Term Investments was $900.2 million in Q4 2021, with the low at $333334.3 in Q1 2022.
• Average Long-Term Investments over 5 years is $224.1 million, with a median of $68.0 million recorded in 2021.
• Across the five-year window, Long-Term Investments soared 232.63% in 2023 and slumped 98.86% in 2024, its largest moves.
• Year by year, Long-Term Investments stood at $900.2 million in 2021, then slipped by 12.31% to $789.4 million in 2022, then retreated by 12.37% to $691.8 million in 2023, then declined by 4.1% to $663.4 million in 2024, then increased by 16.45% to $772.5 million in 2025.
• According to Business Quant data, Long-Term Investments over the past three periods registered $772.5 million, $6.7 million, and $611258.2 for Q4 2025, Q3 2025, and Q2 2025 respectively.